CEO Chris Gibson highlighted significant progress in 2024, including clinical data readouts from REC-617 and REC-994, which showed early efficacy signals and robust safety, respectively. REC-617, a ...

Ben R. Taylor, Chief Financial Officer of RECURSION PHARMACEUTICALS, INC. (NASDAQ:RXRX), sold 21,383 shares of Class A Common Stock at a price of $4.18 on December 29, 2025, according to a Form 4 ...

The 9 Very Best Clothes SteamersFrom a travel steamer the size of a Hydro Flask to the workhorse standing unit found in every costume shop and department store. The 24 Very Best BedsheetsIncluding ...

Condé Nast Traveler readers believe this major US city is the end-all-be-all for shopping destinations in the country.